To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
1. To compare the efficacy of FK506 vs intravenous cyclophosphamide pulses in the treatment
of class III-IV LN.
2. To compare the safety and tolerability of FK506 vs intravenous cyclophosphamide pulses
in the treatment of class III-IV LN.
3. To explore the dosing of FK506 and its effective range of blood concentration.